Clínic Barcelona
Clínic Barcelona
Investigación
17 de septiembre del 2020
Preclinical results support a new combinatorial treatment for follicular Lymphoma to target the tumor cell and its immune microenvironment
Researchers from the “Microenvironment in Lymphoma Pathogenesis and Therapy” IDIBAPS research group have identified a fingerprint to predict the sens1